• Users Online: 120
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 33  |  Issue : 1  |  Page : 63-66

Psychiatric comorbidity in patients with substance use disorder: A hospital-based study

1 Department of Psychiatry, SKIMS Medical College and Hospital, Srinagar, Jammu and Kashmir, India
2 Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India
3 Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Ab Majid Gania
Department of Psychiatry, SKIMS Medical College and Hospital, Srinagar, Jammu and Kashmir
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-9962.200093

Rights and Permissions

Background: Pattern of substance use, profile of substance users, and treatment-seeking differ across cultures and continents. These differences could potentially affect the pattern and perhaps prevalence of dual diagnosis. However, the study of dual diagnosis from de-addiction clinics in India is limited in number and methodology. In this study, we report the prevalence and patterns of psychiatric disorders in subjects attending a de-addiction clinic in a teaching hospital in Srinagar, Kashmir. Methodology: In this cross-sectional study, 300 subjects (>18 years of age) seeking treatment for substance use disorders were screened with Mini International Neuropsychiatric Interview Plus for the presence of psychiatric comorbidity. Subjects were assessed after 4 weeks of complete abstinence from psychoactive substances. Results: Cannabis (26%) was the most common single-use substance. It was followed by polysubstance use (22.3%) and opioids (21.3%). Among the 300 subjects assessed for the purpose of the study, 174 (58%) were found to have dual diagnosis. Psychotic disorders (34%) were the most common psychiatric comorbidity, and it was followed by major depressive disorder (16%) and bipolar affective disorder (16%). Posttraumatic stress disorder (PTSD) was present in 20 (11.5%) subjects. When the groups with or without dual diagnosis were compared, cannabis and benzodiazepine dependence was found to be significantly common in the dual diagnosis group. Conclusions: A high prevalence of dual diagnoses, especially psychotic disorders and also PTSD, in our predominantly cannabis-using subjects attending hospital located in a distinct sociocultural setting in India, highlights the importance of taking into consideration the sociocultural context in which substance use as well as dual diagnoses should be understood.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded338    
    Comments [Add]    
    Cited by others 2    

Recommend this journal